文献速递皮肤肿瘤

昆士兰四十年间第二原发性侵袭性皮肤黑色素瘤的累积发病率变化

Second primary invasive cutaneous melanomas in Queensland over 4 decades.
PubMed 文献 · J Invest Dermatol · 2026-04-07

基于昆士兰肿瘤登记库1982至2022年诊断为第一原发性侵袭性皮肤黑色素瘤的101,035人队列,随访至2023年12月31日,采用竞争风险模型分析第二原发性侵袭性皮肤黑色素瘤(SPICM)的累积发病率变化。9%(n=9224)发生异时性SPICM,40年累积发病率为16.3%(95%CI 15.8-16.8%),10年累积发病率从1982-1991年的4.9%升至2002-2011年的7.9%,2012-2022年为7.3%,多变量分析显示2012-2022年诊断者10年内发生SPICM的风险较1982-1991年高23%(亚风险比1.23,95%CI 1.11-1.35),提示累积发病率可能已趋于平稳。

要点

  • 第一原发性黑色素瘤后40年SPICM累积发病率为16.3%。
  • 10年SPICM累积发病率从1982-1991年4.9%升至2002-2011年7.9%。
  • 2012-2022年诊断者10年内SPICM风险较1982-1991年高23%。

核心结论

  • 在昆士兰这一全球黑色素瘤发病率最高的人群中,SPICM累积发病率可能已趋于平稳。

研究设计与样本

  • 基于昆士兰肿瘤登记库的队列研究,纳入1982至2022年诊断第一原发性侵袭性皮肤黑色素瘤的101,035人,随访至2023年12月31日,采用竞争风险模型分析。

主要发现

  • 9%(n=9224)的患者发生异时性SPICM。
  • 40年SPICM累积发病率为16.3%(95%CI 15.8-16.8%)。
  • 10年累积发病率:1982-1991年4.9%,1992-2001年7.0%,2002-2011年7.9%,2012-2022年7.3%。
  • 多变量分析:2012-2022年诊断者10年内发生SPICM的亚风险比为1.23(95%CI 1.11-1.35),2002-2011年为1.38(95%CI 1.26-1.52),均以1982-1991年为参照。

临床怎么用

  • 对第一原发性黑色素瘤患者应长期监测SPICM风险,尤其关注诊断后10年内。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Second primary invasive cutaneous melanomas (SPICMs) are common and pose an increased risk of death compared with single invasive melanoma only. Using data from the Queensland Oncology Repository, we investigated changes in the cumulative incidence of SPICMs for people diagnosed with a first primary invasive cutaneous melanoma between 1982 and 2022, with follow-up until December 31, 2023. Death due to any cause was treated as a competing risk. Among the 101,035 people in the study cohort, 9% (n = 9224) were diagnosed with a metachronous SPICM. Estimated 40-year cumulative incidence of SPICMs was 16.3% (95% confidence interval = 15.8-16.8%). Ten-year cumulative incidence was 4.9% between 1982 and 1991, 7.0% for 1992-2001, 7.9% for 2002-2011, and 7.3% between 2012 and 2022. After multivariable analysis, people first diagnosed between 2012 and 2022 were 23% more likely to subsequently be diagnosed with a SPICM within 10 years than those first diagnosed in 1982-1991 (subhazard ratio = 1.23, 95% confidence interval = 1.11-1.35), whereas the subhazard ratio was 1.38 (95% confidence interval = 1.26-1.52) for 2002-2011. These results provide evidence that the cumulative incidence of SPICM may have plateaued within a population having the highest rates of melanoma in the world, possibly owing to the impact of long-running sun safety campaigns in Australia combined with increased surveillance.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Youlden DR, Atkinson V, Pinkham MB, et al. Second primary invasive cutaneous melanomas in Queensland over 4 decades. J Invest Dermatol. 2026. PMID: 41944800. doi:10.1016/j.jid.2026.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。